Treatment Effect of the SGLT2 Inhibitor Empagliflozin on Chronic Syndrome of Inappropriate Antidiuresis: Results of a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial - Concepedia

Concepedia

Publication | Open Access

Treatment Effect of the SGLT2 Inhibitor Empagliflozin on Chronic Syndrome of Inappropriate Antidiuresis: Results of a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial

DOI Full Paper Access

72

Citations

41

References

2022

Year

Julie Refardt, Cornelia Imber, Rianne Nobbenhuis, Clara Odilia Sailer, Aaron Haslbauer, Sophie Monnerat, Cemile Bathelt, D. Vogt, Manfred Berres, Bettina Winzeler,

Journal of the American Society of Nephrology

Abstract

This article contains a podcast at.

References

	Year	Citations

Page 1